Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

MODULATION OF INVITRO GROWTH OF MURINE MYELOID-LEUKEMIA BY AN AUTOLOGOUS SUBSTANCE IMMUNOCHEMICALLY CROSS-REACTIVE WITH INSULIN AND ANTIINSULIN SERUM (CROSBI ID 114227)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Vuk-Pavlović, Zvezdana ; Pavelić, Krešimir ; Vuk-Pavlović, Stanimir MODULATION OF INVITRO GROWTH OF MURINE MYELOID-LEUKEMIA BY AN AUTOLOGOUS SUBSTANCE IMMUNOCHEMICALLY CROSS-REACTIVE WITH INSULIN AND ANTIINSULIN SERUM // Blood, 67 (1986), 4; 1031-1035

Podaci o odgovornosti

Vuk-Pavlović, Zvezdana ; Pavelić, Krešimir ; Vuk-Pavlović, Stanimir

engleski

MODULATION OF INVITRO GROWTH OF MURINE MYELOID-LEUKEMIA BY AN AUTOLOGOUS SUBSTANCE IMMUNOCHEMICALLY CROSS-REACTIVE WITH INSULIN AND ANTIINSULIN SERUM

Murine myeloid leukemia secretes a substance immunochemically cross- reactive with insulin (SICRI) both in vivo and in serum-free media. High SICRI concentrations in peripheral blood of tumorous animals do not affect circulating glucose levels. In culture, DNA synthesis rate per leukemic cell is proportional to cell density and is reduced by antiinsulin serum. Culture medium conditioned by leukemia cells as well as SICRI affinity purified from this medium stimulate DNA synthesis in cultured leukemia cells. It appears that autocrine stimulation of murine myeloid leukemia can be mediated in part by an insulin-related growth factor.

in vitro ; murine myeloid leukemia ; immunochemically ; cross-reactive ; antiinsulin serum

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

67 (4)

1986.

1031-1035

objavljeno

0006-4971

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost